The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- Condo Commando 'Splash-tastic' in Spinaway
- Midnight Storm Shakes Up Del Mar Derby
- Jo Jo Warrior Helps Zayat Celebrate Birthday
- Wise Dan Passes Return Test in Flying Colors
- Wise Dan Victorious in Bernard Baruch Return
- Itsmyluckyday Unlikely to Return in Gold Cup
- Plesa Sweeps Juvenile Stakes at Monmouth
- Stonestreet Has Star in Making in Atreides
- Rake Farms, Butler Dominate Minnesota Card
- Itsmyluckyday Outfights Moreno in Woodward